<DOC>
	<DOC>NCT01257542</DOC>
	<brief_summary>15 mg dextromethorphan hydrobromide will be better than placebo with respect to reducing the number of coughs over 6 hours and reducing the subjective severity of cough over 6 hours.</brief_summary>
	<brief_title>Acute Cough Study In Children</brief_title>
	<detailed_description>In light of protocol changes required due to methodological and operational issues, including background noise in cough recordings which could impact data interpretation, the study has been terminated.</detailed_description>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<criteria>Male or female healthy children ages 6 to under 12 years who are symptomatic with a cough due to a cold or acute URTI characterized by: Onset of cold/URTI symptoms occurring no more than 10 days prior to Visit 1; At least 5 coughs during the second 30minute period of the 60minute baseline period. General good health, aside from a common cold, and has no contraindications to the study or rescue medication Acute, subchronic, or chronic cough due to any other condition other than a common cold History of clinically significant cardiovascular, pulmonary, hepatic, renal, neurological, hematological, autoimmune, psychiatric, metabolic, gastrointestinal or endocrine disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>randomized</keyword>
	<keyword>parallel</keyword>
	<keyword>double-blind</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>cough</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>dextromethorphan</keyword>
</DOC>